Axsome Therapeutics, Inc 10-Q for FY2026 Q2
Axsome Therapeutics, Inc. (AXSM)
10-Q
2026-08-10
For: 2026-06-30
View Original
Added on
August 11, 2026
About this 10-Q
Axsome Therapeutics, Inc filed this 10-Q on August 10, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $218.38M
- up 45.5% from $150.04M a year earlier
- Net loss
- $51.31M
- compared with a net loss of $47.97M a year earlier
- Diluted EPS
- -$0.99
- compared with -$0.97 a year earlier